MedTrace Logo

Lamotrigine and Oral Contraceptives

NCT00266149 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2008-04-24

No results posted yet for this study

Summary

The present study evaluates the effect of oral contraceptives on lamotrigine plasma concentrations in a double blind, placebo controlled, cross-over study in patients with epilepsy.

Conditions

Interventions

DRUG

Oral contraception

DRUG

Lamotrigine

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Jakob Christensen, MD, PhD · Department of Neurology, Aarhus University Hospital, 8000 Aarhus C

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-06-30
Completion
2005-05-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00266149 on ClinicalTrials.gov